Ebselen decreases oxygen free radical production and iron concentrations in the hearts of chronically iron-overloaded mice

Biological Research for Nursing

Volumn 6, Issue 1, 2004, Pages 37-45

  Davis, Matthew T ^a   Bartfay, Wally J ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WINDSOR   (Canada)

Author keywords

Aldehyde; Ebselen; Glutathione peroxidase; Heart; Iron; Oxygen free radical

Indexed keywords

ANTIOXIDANT; EBSELEN; FREE RADICAL; GLUTATHIONE PEROXIDASE; IRON; ORGANOSELENIUM DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRROLE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; HEART MUSCLE; IRON OVERLOAD; LIPID PEROXIDATION; MALE; METABOLISM; MOUSE; MOUSE STRAIN; RANDOMIZATION;

ANIMALS; ANTIOXIDANTS; AZOLES; CARDIOMYOPATHIES; CHRONIC DISEASE; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FREE RADICALS; GLUTATHIONE PEROXIDASE; IRON; IRON OVERLOAD; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; ORGANOSELENIUM COMPOUNDS; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES;

EID: 3843144067     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800403261350     Document Type: Article

References (51)

1. Bartfay WJ, Bartfay E. 2000a. Iron-overload cardiomyopathy: evidence for a free radical - mediated mechanism of injury and dysfunction in a murine model. Biol Res Nurs 2(1):49-59.
2. Bartfay WJ, Bartfay E. 2000b. Systemic oxygen-free radical production in iron-loaded mice. Western J Nurs Res 22(8):927-35.
3. Bartfay WJ, Bartfay E. 2002. Decreasing effects of iron toxicosis on selenium and glutathione peroxidase activity. Western J Nurs Res 24(2):119-31.
4. Bartfay WJ, Butany J, Lehotay DC, Sole MJ, Hou D, Bartfay E, Liu PP. 1999. A biochemical, histochemical, and electron microscopic study on the effects of iron-loading on the hearts of mice. Cardiovasc Pathol 8(6):305-14.
5. Bartfay WJ, Davis MT, Medves JM, Lugowski S. 2003. Milk whey protein decreases oxygen free radical production in a murine model of chronic iron-overload cardiomyopathy. Can J Cardiol (in press).
6. Bartfay WJ, Dawood F, Wen WH, Lehotay DC, Hou D, Bartfay E, Luo X, Backx PH, Liu PP. 1999. Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. Cardiovasc Res 43(4):892-900.
7. Bartfay WJ, Hou D, Brittenham GM, Bartfay E, Sole MJ, Lehotay D, Liu PP. 1998. The synergistic effects of vitamin E and selenium in iron-overloaded mouse hearts. Can J Cardiol 14(7):937-41.
8. Boireau A, Dubedat P, Bordier F, Coimbra M, Meunier M, Imperato A, Moussaoui S. 1999. Effects of ebselen, a glutathione peroxidase mimic, in several models of mitochondrial dysfunction. Ann N Y Acad Sci 893:254-7.
9. Borgaonkar MR. 2003. Hemochromatosis. More common than you think. Can Fam Phys 49:36-43.
10. Bottomley SS. 1998. Secondary iron-overload disorders. Semin Hematol 35(1):77-86.
11. Chen YY, Ho KP, Xia Q, Qian ZM. 2002. Hydrogen peroxide enhances iron-induced injury in isolated heart and ventricular cardiomyocyte in rats. Mol Cell Biochem 231(1-2):61-8.
12. Crowe S, Bartfay WJ. 2002. Amlodipine decreases iron uptake and oxygen free radical production in the heart of chronically iron overloaded mice. Biol Res Nurs 3(4):189-97.
13. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, and others. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Gen 13(4):399-408.
14. Fraga C, Oteiza P. 2002. Iron toxicity and antioxidant nutrients. Toxicology 180(1):23.
15. Handa Y, Kaneko M, Takeuchi H, Tsuchida A, Kobayashi H, Kubota T. 2000. Effect of an antioxidant, ebselen, on development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Surg Neurol 53(4):323-9.
16. Haraoka M, Matsumoto T, Mizunoe Y, Takahashi K, Kubo S, Koikawa Y, Tanaka M, Sakamoto Y, Sakumoto M, Nagafuji T. 1995. Effect of ebselen on renal scarring in rats following renal infection. Chemotherapy 41(3):208-13.
17. Hershko C, Link G, Cabantchik I. 1998. Pathophysiology of iron overload. Ann N Y Acad Sci 850:191-201.
18. Horwitz LD, Rosenthal EA. 1999. Iron-mediated cardiovascular injury. Vasc Med 4(2):93-9.
19. Hoshida S, Kuzuya T, Nishida M, Yamashita N, Hori M, Kamada T, Tada M. 1994. Ebselen protects against ischemia-reperfusion injury in a canine model of myocardial infarction. Am J Physiol 267(6 Pt 2):H2342-7.
20. Imai H, Masayasu H, Dewar D, Graham DI, Macrae IM. 2001. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32(9):2149-54.
21. Ishii Y, Hashimoto K, Hirano K, Morishima Y, Mochizuki M, Masuyama K, Nomura A, Sakamoto T, Uchida Y, Sagai M, and others. 2000. Ebselen decreases ozone-induced pulmonary inflammation in rats. Lung 178(4):225-34.
22. Kobayashi T, Ohta Y, Yoshino J. 2001. Preventive effect of ebselen on acute gastric mucosal lesion development in rats treated with compound 48/80. Eur J Pharmacol 414(2-3):271-9.
23. Kremastinos DT. 2001. Heart failure in beta-thalassemia. Congest Heart Fail 7(6):312-14.
24. Lass A, Witting P, Stocker R, Esterbauer H. 1996. Inhibition of copper- and peroxyl radical-induced LDL lipid oxidation by ebselen: antioxidant actions in addition to hydroperoxide-reducing activity. Biochim Biophys Acta 1303(2):111-18.
25. Li CK, Luk CW, Ling SC, Chik KW, Yuen HL, Li CK, Shing MM, Chang KO, Yuen PM. 2002. Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: retrospective study. Hong Kong Med J 8(4):255-60.
26. Li J, Chen JJ, Zhang F, Zhang C. 2000. Ebselen protection against hydrogen peroxide-induced cytotoxicity and DNA damage in HL-60 cells. Acta Pharmacol Sin 21(5):455-9.
27. Lieu PT, Heiskala M, Peterson PA, Yang Y. 2001. The roles of iron in health and disease. Mol Aspects Med 22(1-2):1-87.
28. Link G, Konijn AM, Hershko C. 1999. Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells. J Lab Clin Med 133(2):179-88.
29. Lloyd RV, Hanna PM, Mason RP. 1997. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Radic Biol Med 22(5):885-8.
30. Luo XP, Yazdanpanah M, Bhooi N, Lehotay DC. 1995. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Ann Biochem 228(2):294-8.
31. Maiorino M, Roveri A, Ursini F. 1992. Antioxidant effect of ebselen (PZ 51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity. Arch Biochem Biophys 295(2):404-9.
32. Mason RP, Hanna PM, Burkitt MJ, Kadiiska MB. 1994. Detection of oxygen-derived radicals in biological systems using electron spin resonance. Environ Health Persp 102(suppl 10):33-6.
33. Maulik N, Yoshida T, Das DK. 1998. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med 24(5):869-75.
34. McMaster D, Bell N, Anderson P, Love AH. 1990. Automated measurement of two indicators of human selenium status, and applicability to population studies. Clin Chem 36(2):211-16.
35. Moussaoui S, Obinu MC, Daniel N, Reibaud M, Blanchard V, Imperato A. 2000. The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease. Exp Neurol 166(2):235-45.
36. Myers ML, Farhangkhoee P, Karmazyn M. 1998. Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Cardiovasc Res 40(2):290-6.
37. Namura S, Nagata I, Takami S, Masayasu H, Kikuchi H. 2001. Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 32(8):1906-11.
38. Noguchi N, Yoshida Y, Kaneda H, Yamamoto Y, Niki E. 1992. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol 44(1):39-44.
39. Ogawa A, Yoshimoto T, Kikuchi H, Sano K, Saito I, Yamaguchi T, Yasuhara H. 1999. Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial. Cerebrovasc Dis 9(2):112-18.
40. Ohta Y, Kobayashi T, Inui K, Yoshino J, Nakazawa S. 2002. Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Jap J Pharmacol 90(4):295-303.
41. Olivieri NF. 1999. The beta-thalassemias. N Engl J Med 341(2):99-109.
42. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. 1999. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341(10):718-24.
43. Ong ML, Hatle LK, Lai VM, Bosco J. 2002. Non-invasive cardiac assessment in beta-thalassaemia major. Int J Clin Pract 56(5):345-8.
44. Pietrangelo A. 2003. Haemochromatosis. Gut 52(suppl 2):II23-30.
45. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T, Ishibashi S. 1998. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 42(2):269-77.
46. Sies H, Arteel GE. 2000. Interaction of peroxynitrite with selenoproteins and glutathione peroxidase mimics. Free Radic Biol Med 28(10):1451-5.
47. Sies H, Masumoto H. 1997. Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol 38:229-46.
48. Sochaski MA, Bartfay WJ, Thorpe SR, Baynes JW, Bartfay E, Lehotay DC, Liu PP. 2002. Lipid peroxidation and protein modification in a mouse model of chronic iron overload. Metabolism 51(5):645-51.
49. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H. 1998. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke 29(1):12-17.
50. Yazdanpanah M, Luo X, Lau R, Greenberg M, Fisher LJ, Lehotay DC. 1997. Cytotoxic aldehydes as possible markers for childhood cancer. Free Radic Biol Med 23(6):870-8.
51. Zhang M, Nomura A, Uchida Y, Iijima H, Sakamoto T, Iishii Y, Morishima Y, Mochizuki M, Masuyama K, Hirano K, and others. 2002. Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free Radic Biol Med 32(5):454-64.